Showing results (1-10 of 285) with videos related to
Sort By:
Pageof 29
Trends in Pharmacological Sciences|March 19, 2021
Efflux Limits Tumor Drug Delivery Despite Disrupted BBBJessica I Griffith, Jann N Sarkaria, William F ElmquistCurrent Cancer Drug Targets|December 8, 2004
Mammalian target of rapamycin (mTOR) inhibitors as anti-cancer agentsRavi D Rao, Jan C Buckner, Jann N SarkariaProceedings of the National Academy of Sciences of the United States of America|February 9, 2011
Nonhomologous end joining drives poly(ADP-ribose) polymerase (PARP) inhibitor lethality in homologous recombination-deficient cellsAnand G Patel, Jann N Sarkaria, Scott H KaufmannSeminars in Radiation Oncology|June 9, 2015
Radiation Therapy Oncology Group 9802: Controversy or Consensus in the Treatment of Newly Diagnosed Low-Grade Glioma?Nadia N Laack, Jann N Sarkaria, Jan C BucknerAdvanced Science (Weinheim, Baden-Wurttemberg, Germany)|September 15, 2022
Perivascular Stromal Cells Instruct Glioblastoma Invasion, Proliferation, and Therapeutic Response within an Engineered Brain Perivascular Niche ModelMai T Ngo, Jann N Sarkaria, Brendan A C HarleyPharmacological Research|June 22, 2017
Drug delivery to melanoma brain metastases: Can current challenges lead to new opportunities?Gautham Gampa, Shruthi Vaidhyanathan, Jann N Sarkaria, et al.International Journal of Molecular Sciences|July 28, 2026
Divergent Roles of Canonical and Non-Canonical Mismatch Repair in Regulating Temozolomide Sensitivity in GlioblastomaShiv K Gupta, Sonia Jain, Teddy R Friedman, et al.Frontiers in Bioscience : a Journal and Virtual Library|November 29, 2002
Combination of epidermal growth factor receptor targeted therapy with radiation therapy for malignant gliomasSunil Krishnan, Ravi D Rao, C David James, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 31, 2014
Factors influencing the CNS distribution of a novel MEK-1/2 inhibitor: implications for combination therapy for melanoma brain metastasesShruthi Vaidhyanathan, Rajendar K Mittapalli, Jann N Sarkaria, et al.Cancer Research|November 26, 2013
Cyclophilin B supports Myc and mutant p53-dependent survival of glioblastoma multiforme cellsJae Won Choi, Mark A Schroeder, Jann N Sarkaria, et al.Pageof 29